Aidoc has raised $150M to accelerate development of its CARE foundation model for clinical AI in radiology and beyond.
Key Details
- 1Aidoc secured $150M in funding, bringing total raised to $370M since 2016.
- 2Investors include major U.S. hospital systems and venture capital firms; $40M is a revolving credit line.
- 3Funds will accelerate CARE, a clinical-grade foundation AI model adaptable across diseases.
- 4CARE aims to cover 90% of clinically relevant diseases within three years, including cancer and cardiovascular conditions.
- 5Aidoc supports decision-making for over 45 million patients annually across 150+ health systems.
- 6Company has over 20 FDA clearances and plans significant investment via partnerships with Nvidia and AWS.
Why It Matters
Aidoc's funding enables rapid development and scaling of foundational imaging AI, with potential to cover most clinically relevant diseases and support broader, system-wide AI adoption. Such progress could shift the landscape for radiologists and health systems, impacting workflow, diagnostics, and patient outcomes.
Source
Radiology Business
Related News
•HealthExec
Mayo Clinic Sued Over Alleged AI Improprieties and Whistleblower Retaliation
A former Mayo Clinic research director sues the institution, alleging retaliation after raising concerns about improper AI use affecting patient safety and data integrity.
•Radiology Business
Majority of Patients Want Disclosure When AI Used in Imaging
A new survey finds that nearly all patients want to be informed when AI is utilized in medical imaging interpretation.
•Radiology Business
Private Equity Backs AIRS Medical to Expand MRI AI Globally
TA Associates is investing in AIRS Medical to accelerate its global expansion of AI-powered MRI efficiency solutions.